A Multicenter, Randomized, Parallel-Group, Double-Blind, Placebo-Controlled Phase II Clinical Trial to Evaluate the Efficacy and Safety of QY201 Tablets in Subjects With Non-Segmental Vitiligo

Clinical trial NCT07712523 · RECRUITING

Trial details

NCT number: NCT07712523
Sponsor: E-nitiate Biopharmaceuticals (Hangzhou) Co., Ltd.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Adult Subjects With Non-Segmental Vitiligo

Start date: 2025-11-05
Primary completion: 2026-12-31
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.